MYH9 is abnormally highly expressed in esophageal squamous cell carcinoma [17], breast cancer [18], epithelial ovarian cancer [19] and acute myeloid leukemia [20] and is associated with poor prognosis. Here, MYH9 is linked to breast cancer.